News

News

Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device

TAMPA, Fla., July 29, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,

July 29, 2020Read More
Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.

TAMPA, Fla., June 16, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,

June 16, 2020Read More
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

Merger Establishes US and EMEA Presence for the Preeminent Chinese Structural Heart Company HANGZHOU, China and CAESAREA, Israel and TAMPA, Florida

January 09, 2019Read More
Current Cerebral Embolic Protection Landscape

Current Cerebral Embolic Protection Landscape

Keystone Heart TriGUARD Data ReviewJeffrey MosesConclusions:Overt and Covert stroke are significant complications of TAVR which may be o

December 03, 2018Read More
REFLECT Clinical Update with TriGUARD3 Cerebral Embolic Protection Device

REFLECT Clinical Update with TriGUARD3 Cerebral Embolic Protection Device

Tamim NazifConclusions:TriGUARD 3™ offers complete 3 vessel cerebral embolic protection for TAVR Specific design improvements optimize

December 03, 2018Read More

Newslist

Subscribe to our Newsletter

Be the first one to get the latest updates, events and more!

Join Keystone Heart at TCT2018
By keyheart41 / September 13, 2018

Join Keystone Heart at TCT2018

We invite you to explore and discuss with world-renown physicians the importance of complete cerebral embolic protection with TAVR. Please join us for the Keystone Heart Lunch Symposium during ...

Read More
TCT2018 Plans
By keyheart41 / August 16, 2018

TCT2018 Plans

Keystone Heart is excited to share with you our plans during TCT2018. TCT is the largest interventional cardiovascular medicine meeting focusing on education in the field of interventional and vascular medicine ...

Read More
Brain Lesions
2019
By keyheart41 / June 18, 2018

What is Cerebral Reserve and Why Does It Matter?

Cerebral reserve is the brain’s ability in the face of an insult (e.g clinically overt stroke, trauma) or multiple insults (new clinically silent lesions) over time and refers to the amount of brain damage the brain can ...

Read More
Cerebral Reserve
2018
By keyheart41 / June 7, 2018

Why Care About Embolic Brain Lesions When We’re Talking About Cardiovascular Issues?

You may be wondering why it is important to discuss brain lesions in relation to TAVI and other cardiovascular procedures. Through our years of experience and research ....

Read More
Triguard

The Only CE Marked Cerebral Embolic Protection Device Designed to Cover all Three Major Aortic Vessels.

Cerebral Embolic Protection Device

Stay Updated on the latest events from Keystone Heart.

Skip to content